Kronos Bio Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Kronos Bio, Inc. |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Kronos Bio dropped its 2024 10-K. Check financials.
AI Summary
Kronos Bio, Inc. filed its 2024 10-K on March 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is headquartered in San Mateo, California. The filing details its financial performance and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Kronos Bio's financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Kronos Bio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K report.)
- 2025-03-18 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Kronos Bio, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-18 (date) — Filing date
- San Mateo, CA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is Kronos Bio's primary business activity?
Kronos Bio, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When did Kronos Bio file its 2024 10-K?
Kronos Bio filed its 2024 10-K on March 18, 2025.
What is the fiscal year end for Kronos Bio?
The fiscal year end for Kronos Bio is December 31.
Where is Kronos Bio headquartered?
Kronos Bio, Inc. is headquartered in San Mateo, California.
What is the SEC file number for Kronos Bio?
The SEC file number for Kronos Bio is 001-39592.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding Kronos Bio, Inc..